Clinical Kidney Journal
Longitudinal Assessment of Cognitive Decline in Hemodialysis Patients: Unveiling Sex Disparities Sex and cognitive decline in hemodialysis patients
By Hannah Schäfer, Matthias C. Braunisch, Roman Günthner and 6 others.
Abstract
Abstract Background Numerous studies have delved into the prevalence, risk factors, and outcomes associated with cognitive impairment in hemodialysis patients. However, a scarcity of data exists regarding the trajectory of cognitive decline and potential contributing factors. Methods We recruited 247 prevalent hemodialysis patients for this study. Baseline and follow-up cognitive assessments were conducted in 90 patients using the Montreal Cognitive Assessment (MoCA) at a two-year interval. To identify potential predictors of cognitive decline, we analyzed traditional risk factors alongside dialysis-related variables. Additionally, surrogate parameters of vascular calcification and arterial stiffness, such as T50 values and pulse wave velocity, were investigated. Results After a two-year follow-up period (24.3 ± 1.05 months), MoCA test results revealed a significant decline in cognitive function (- 1.8 ± 3.2 points, p < 0.001). Overall, 37 patients (41%) exhibited cognitive decline, defined as a decrease in MoCA score of more than 2 points, indicating disease progression. The median change in MoCA score differed significantly between males (-3.0, range 0.0 to -5 points) and females (0.0, range 1.0 to -1.75 points, p = 0.002). This finding was corroborated by multivariable analyses adjusted for age, educational level, diabetes and blood pressure measurements (regression coefficient -2.5, p = 0.006). The association was further confirmed in a comparison between patients with stable and declining cognitive function (regression coefficient 2.65, odds ratio 14.2, p = 0.007). None of the other variables reached statistical significance. Conclusions Our findings underscore a substantial deterioration in cognitive function over time among hemodialysis patients. Notably, our data reveal a more rapid decline in cognitive function among males, shedding light on previously unrecognized sex differences in this patient population.





